Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia.
Saved in:
| Title: | Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia. |
|---|---|
| Authors: | Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam a.p.kater@amc.uva.nl., van Oers MHJ; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam., van Norden Y; Department of Hematology - HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam., van der Straten L; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht., Driessen J; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam., Posthuma WFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft.; Department of Hematology, Leiden University Medical Center., Schipperus M; Department of Hematology, Haga Hospital, the Hague., Chamuleau MED; Department of Hematology, VU University Medical Center, Amsterdam., Nijland M; Department of Hematology, University Medical Center, Groningen., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam., Van Gelder M; Department of Hematology, Maastricht University Medical Center., Hoogendoorn M; Department of Internal Medicine, Medical Center, Leeuwarden., De Croon F; Department of Internal Medicine, Ikazia Hospital, Rotterdam., Wittebol S; Department of Internal Medicine, Gelderland Valley Hospital, Ede., Kerst JM; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam., Marijt EWA; Department of Hematology, Leiden University Medical Center., Raymakers RAP; Department of Hematology, University Medical Center, Utrecht., Schaafsma MR; Department of Hematology, Medical Spectrum Twente, Enschede., Dobber JA; Laboratory Special Hematology, Academic Medical Center, Amsterdam, the Netherlands., Kersting S; Department of Hematology, Haga Hospital, the Hague., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht. |
| Corporate Authors: | HOVON CLL study group |
| Source: | Haematologica [Haematologica] 2019 Jan; Vol. 104 (1), pp. 147-154. Date of Electronic Publication: 2018 Aug 16. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
